BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10097488)

  • 1. [Biochemical indicators of metabolic disorders in bone tissue. I. Bone resorption].
    Minchenko BI; Benevolenskiĭ DS; Tishenina RS
    Klin Lab Diagn; 1999 Jan; (1):8-15. PubMed ID: 10097488
    [No Abstract]   [Full Text] [Related]  

  • 2. Collagen turnover in bone diseases.
    Robins SP
    Curr Opin Clin Nutr Metab Care; 2003 Jan; 6(1):65-71. PubMed ID: 12496682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Processes of bone tissue reconstruction and their regulation].
    Galus K
    Pol Arch Med Wewn; 1974 Jan; 51(1):77-90. PubMed ID: 4820153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical indicators of metabolic disorders in bone tissue. I. Bone formation].
    Minchenko BI; Benevolenskiĭ DS; Tishenina RS
    Klin Lab Diagn; 1999 Apr; (4):11-7. PubMed ID: 10356898
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical markers of bone metabolism.
    Tohmé JF; Seibel MJ; Silverberg SJ; Robins SP; Bilezikian JP
    Z Rheumatol; 1991; 50(3):133-41. PubMed ID: 1927060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical basis of bone resorption markers].
    Ichimura S; Iwamoto J
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():228-35. PubMed ID: 11979912
    [No Abstract]   [Full Text] [Related]  

  • 7. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part III of IV parts; PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism.
    Parfitt AM
    Metabolism; 1976 Sep; 25(9):1033-69. PubMed ID: 785157
    [No Abstract]   [Full Text] [Related]  

  • 8. Is bone alkaline phosphatase an adequate marker of bone metabolism during acute corticosteroid treatment?
    Peretz A; Moris M; Willems D; Bergmann P
    Clin Chem; 1996 Jan; 42(1):102-3. PubMed ID: 8565202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical aspects of bone metabolism -- correlations to bone morphology (report) (author's transl)].
    Haas HG; Dambacher MA; Lauffenburger T; Olah AJ
    Verh Dtsch Ges Pathol; 1974; 58():135-6. PubMed ID: 4460456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic bone diseases].
    Dequeker J; Van Walleghem U; De Schepper S; Roh YS; Gautama K; Van Dessel D; Burssens A
    R I Dent J; 1973; 28(6):390-450. PubMed ID: 4594736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of bone biopsy in the diagnosis of calcipenic osteopathy].
    Lozano-Tonkin C
    Z Rheumaforsch; 1972; 31(9):358-66. PubMed ID: 4653072
    [No Abstract]   [Full Text] [Related]  

  • 13. New concepts in bone metabolism: clinical implications.
    Mundy GR
    Hosp Pract (Off Ed); 1991; 26 Suppl 1():7-12. PubMed ID: 1898515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of collagen crosslinks; potential biomarkers for bone disorders.
    McGuinness BJ; Casserly UM; Power MJ; Fottrell PF
    Biochem Soc Trans; 1995 May; 23(2):386S. PubMed ID: 7672419
    [No Abstract]   [Full Text] [Related]  

  • 15. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracycline-based histological analysis of bone remodeling.
    Frost HM
    Calcif Tissue Res; 1969; 3(3):211-37. PubMed ID: 4894738
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteocalcin and specific markers of bone resorption in sickle cell disease.
    Bolarin DM; Azinge EC
    Acta Physiol Hung; 2010 Sep; 97(3):290-6. PubMed ID: 20843767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of bone metabolism and metabolic bone diseases].
    Baleva R
    Vutr Boles; 1977; 16(3):8-14. PubMed ID: 197716
    [No Abstract]   [Full Text] [Related]  

  • 19. Skeletal renewal and metabolic bone disease.
    Harris WH; Heaney RP
    N Engl J Med; 1969 Jan; 280(5):253-9 contd. PubMed ID: 4883109
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone collagenase in assessment of the clinical course of metabolic bone disease.
    Gardner B; Wallach S; Gray H; Baker RK
    Surg Forum; 1971; 22():435-7. PubMed ID: 4330605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.